过去一年中添加的文章，按日期排序
A randomized double-blind Phase IIb trial to evaluate the efficacy of ChAd63-KH for the treatment of post kala-azar dermal leishmaniasis.
BM Younis, R Wiggins, EAG Khalil, M Osman… - medRxiv, 2024 - medrxiv.org
90 天前 - … In a recent Phase IIa clinical trial, the candidate leishmaniasis vaccine 27
ChAd63-KH was shown to be safe and immunogenic in Sudanese patients with post kala- 28 …
ChAd63-KH was shown to be safe and immunogenic in Sudanese patients with post kala- 28 …